The role of naloxegol in the management of opioid-induced bowel dysfunction. | Therap Adv Gastroenterol;9(5): 736-46, 2016 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

The role of naloxegol in the management of opioid-induced bowel dysfunction.

Leppert, Wojciech; Woron, Jaroslaw.

Affiliation

Leppert W; Chair and Department of Palliative Medicine, Poznan University of Medical Sciences, Osiedle Rusa 25 A, 61-245 Poznan, Poland.
Woron J; Department of Clinical Pharmacology, Jagiellonian University College of Medicine, Krakow, Poland.

Therap Adv Gastroenterol ; 9(5): 736-46, 2016 Sep.

Article in En | MEDLINE | ID: mdl-27582887

Key words

methylnaltrexone; naloxegol; opioid-induced bowel dysfunction; opioid-induced constipation; oxycodone/naloxone

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Therap Adv Gastroenterol Year: 2016 Document type: Article Affiliation country: Poland Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Therap Adv Gastroenterol Year: 2016 Document type: Article Affiliation country: Poland Country of publication: United kingdom